Related Experiment Video
Updated: Jun 9, 2025
07:39
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
34
DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity
Pinhua Wang1, Sunayana Sarkar2, Menghuan Zhang1
1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China.
Elife
|October 22, 2024
Summary
DYRK1A kinase regulates cell growth by inhibiting the TSC complex, promoting mTORC1 activity. This mechanism is conserved in Drosophila, highlighting DYRK1A
Area of Science:
- Cell Biology
- Developmental Biology
- Biochemistry
Background:
- DYRK1A (Dual-specificity Yak-like kinase 1A) is crucial for organ growth but its regulatory mechanisms are unclear.
- DYRK1A is implicated in intellectual disabilities, microcephaly, and Down syndrome.
- DYRK1A influences cell cycle, vesicle trafficking, and microtubule assembly.
Purpose of the Study:
- To elucidate the role of DYRK1A in regulating cell size and organ growth.
- To identify the molecular targets and pathways through which DYRK1A exerts its effects.
- To investigate the conserved function of DYRK1A in growth regulation.
Main Methods:
- Mammalian cell culture and DYRK1A knockdown.
- Proteomic analysis to identify DYRK1A interacting proteins.
- Western blotting to detect protein phosphorylation.
- Drosophila neuromuscular junction assays.
Main Results:
- DYRK1A knockdown in mammalian cells reduced cell size, dependent on mTORC1.
- DYRK1A was found to interact with TSC1/TSC2 complex proteins.
- DYRK1A phosphorylates TSC2 at T1462, inhibiting TSC activity and activating mTORC1.
- Overexpression of RHEB rescued reduced cell growth in DYRK1A knockdown cells and Drosophila mnb mutants.
Conclusions:
- DYRK1A promotes cell growth by inhibiting the TSC complex via phosphorylation of TSC2, thereby activating mTORC1.
- This mechanism of DYRK1A-mediated mTORC1 regulation is conserved from flies to mammals.
- DYRK1A's role in growth regulation offers potential therapeutic targets for related developmental disorders.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:26Receptor Tyrosine Kinases
12.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.4K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K